FSANZ Research Grants
The Fertility Society of Australia and New Zealand (FSANZ) is pleased to announce that it is currently seeking applications from financial members of the Society for financial support of research projects in 2021-2023.
With the generous support of Ferring Pharmaceuticals and Merck the 2021 "call for applications" process is now open for the following research grant initiatives:
"Ferring FSANZ 'Leaders in Fertility Research and Education' Grant"
"Merck FSANZ ‘Leaders in Innovation / Fertility’ Research Grant"
Each year, $35,000 will be available to support research projects in the areas of reproductive medicine, reproductive biology and reproductive epidemiology.
Furthermore, $15,000 with be available for research project(s) aiming to improve aspects of telehealth/remote engagement and improve the patient journey and care within the area of reproductive medicine.
The FSANZ acknowledges Ferring for their generous sponsorship of these research grants.
Each year grants to a total of $50,000 (with a maximum of $25,000 per grant) will be available through the “Merck FSANZ ‘Leaders in Innovation / Fertility’ Research Grant” to support research projects in the areas of:
- Innovations in ART Patient care and patient-reported outcomes
- Real-world evidence generation and/or analysis
- New models of care with telemedicine and digital health
The FSANZ acknowledges Merck for their generous sponsorship of these research grants.